Health-related quality of life is an important issue in the treatment of breast cancer and healthstate utility values (HSUVs) are essential for cost-utility analysis.
This study aimed to systematically identify HSUVs for early (EBC) and metastatic (MBC) breast
cancer in the current literature and provide a pooled estimate of HSUVs for identifiable health
states. The feasibility of generating a definitive list of HSUVs to be used in future economic
evaluation was explored.
History
Ethics
There is no personal data or any that requires ethical approval
Policy
The data complies with the institution and funders' policies on access and sharing